(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIORASI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BIORASI

ST13

US500000087945066

Class

35

Filing

87945066

Registration

5655068

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

02/13/2026

Trademark type

Combined

Nice classes

35

Filing date

06/01/2018

Registration date

01/15/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/12/2026

Last transaction

02/13/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

First use anywhere

12/18/2002

First use in commerce

12/18/2002

Drawing code

3

Owner type

16

Owner location

MIAMI, FL

Examiner

JOHNSON, DONALD

Current location

Historical data usage

Mark description

The mark consists of the word "biorasi" to the right of two rounded, overlapping triangles that have been turned 90 degrees to the left.

Holders and representatives

Holders

BIORASI, LLC
BIORASI, LLC

Representatives

BIORASI, LLC

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consultation in the field of clinical trials and developmentbiosimilar trialsclinical servicesprogram developmentregulatory guidance and compliancesafety and pharmacovigilancedata science and biometrics; Business project management services; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Business consulting and management in the field of clinical trialsproviding information management services; Business management and consultation in the field of clinical trials and developmentbiosimilar trialsclinical servicesprogram developmentregulatory guidance and compliancesafety and pharmacovigilancedata science and biometrics; Interactive record-keeping services for use in risk management and regulatory compliance by insurers and professionals in the medical field; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval

Publications

History of USPTO decisions and trademark events.

16 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

02/12/2026

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

02/12/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/01/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/29/2024

ES8R

TEAS SECTION 8 RECEIVED

01/15/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/15/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/30/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

01/15/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/30/2018

PUBO

PUBLISHED FOR OPPOSITION

10/30/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/10/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/22/2018

DOCK

ASSIGNED TO EXAMINER

09/20/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/09/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/08/2018

NWAP

NEW APPLICATION ENTERED

06/05/2018

Continuous trademark protection

Get notified about every new filing that threatens BIORASI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.